We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$1.43B
AUM Growth
+$297M
Cap. Flow
+$228M
Cap. Flow %
16%
Top 10 Hldgs %
15.34%
Holding
1,414
New
222
Increased
745
Reduced
184
Closed
249

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.4M
2
AAPL icon
Apple
AAPL
+$9.16M
3
MSFT icon
Microsoft
MSFT
+$6.62M
4
META icon
Meta Platforms (Facebook)
META
+$5.96M
5
AMZN icon
Amazon
AMZN
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.25%
3 Healthcare 11.99%
4 Industrials 10.61%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKSD
1076
DELISTED
LSC Communications, Inc.
LKSD
$24K ﹤0.01%
1,608
-2,698
-63% -$42.9K
CALY
1077
Callaway Golf Company
CALY
$3.26B
$23K ﹤0.01%
+1,619
New +$23.2K
SNCR
1078
DELISTED
Synchronoss Technologies
SNCR
$23K ﹤0.01%
290
+72
+33% +$6.96K
AKAO
1079
DELISTED
Achaogen Inc
AKAO
$22K ﹤0.01%
+2,075
New +$26K
SYKE
1080
DELISTED
SYKES Enterprises Inc
SYKE
$21K ﹤0.01%
+683
New +$20.6K
IPHS
1081
DELISTED
Innophos Holdings, Inc.
IPHS
$21K ﹤0.01%
445
-262
-37% -$12.2K
ACET
1082
DELISTED
Aceto Corp
ACET
$21K ﹤0.01%
2,002
+526
+36% +$5.53K
HIBB
1083
DELISTED
Hibbett, Inc. Common Stock
HIBB
$21K ﹤0.01%
1,043
-480
-32% -$7.92K
ASRT
1084
DELISTED
Assertio
ASRT
$20K ﹤0.01%
42
-54
-56% -$21K
LJPC
1085
DELISTED
La Jolla Pharmaceutical Company
LJPC
$20K ﹤0.01%
+625
New +$20.4K
INSM icon
1086
Insmed
INSM
$23.2B
$19K ﹤0.01%
+625
New +$18.5K
ROCK icon
1087
Gibraltar Industries
ROCK
$1.34B
$19K ﹤0.01%
567
-582
-51% -$18.6K
NXGN
1088
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$19K ﹤0.01%
1,394
-784
-36% -$11.3K
AIMT
1089
DELISTED
Aimmune Therapeutics
AIMT
$19K ﹤0.01%
+500
New +$16.1K
FINL
1090
DELISTED
Finish Line
FINL
$19K ﹤0.01%
1,315
-907
-41% -$9.77K
CMTL icon
1091
Comtech Telecommunications
CMTL
$51.8M
$18K ﹤0.01%
+801
New +$17.1K
LXRX icon
1092
Lexicon Pharmaceuticals
LXRX
$1.02B
$18K ﹤0.01%
+1,825
New +$19K
EGOV
1093
DELISTED
NIC Inc
EGOV
$18K ﹤0.01%
1,080
-370
-26% -$6.24K
ANF icon
1094
Abercrombie & Fitch
ANF
$4.17B
$17K ﹤0.01%
+991
New +$15K
MSTR icon
1095
Strategy Inc
MSTR
$33.5B
$17K ﹤0.01%
1,330
-960
-42% -$12.9K
PLAB icon
1096
Photronics
PLAB
$1.79B
$17K ﹤0.01%
+1,954
New +$17.8K
RGR icon
1097
Sturm, Ruger & Co
RGR
$610M
$17K ﹤0.01%
+297
New +$15.5K
VNDA icon
1098
Vanda Pharmaceuticals
VNDA
$312M
$17K ﹤0.01%
+1,125
New +$16.7K
KEM
1099
DELISTED
KEMET Corporation
KEM
$17K ﹤0.01%
+1,106
New +$21.1K
BNED icon
1100
Barnes & Noble Education
BNED
$412M
$16K ﹤0.01%
+19
New +$12.6K

Similar funds

Pacer Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Pacer Advisors held 1,414 positions worth $1.43B, up 26% from $1.13B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pacer Advisors deployed $228M of net new capital in Q4 2017, opening 222 new positions and adding to 745 existing holdings. Its largest new stake was Equinor: 118,925 shares worth $2.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.14M trimmed.

  • Pacer Advisors's largest Q4 2017 buy was Equinor: 118,925 shares worth $2.55M.
  • Pacer Advisors added most to Alphabet (Google) Class A in Q4 2017, an estimated $11.4M increase.
  • Pacer Advisors's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $3.14M.
  • Pacer Advisors fully exited Adient in Q4 2017, selling an estimated $1.67M.
  • Pacer Advisors's ten largest holdings make up 15% of its $1.43B portfolio in Q4 2017.
  • Pacer Advisors opened 222 new positions and closed 249 in Q4 2017.
  • Pacer Advisors's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.